Researchers at UCLA received a $2.7 million federal grant to help HIV-positive adults at risk of heart disease.
The National Institutes of Health had awarded the grant to two scientists who aim to address the under-prescribing of heart medication to people with HIV, the university announced on July 23.
“Adults with HIV have an increased risk of cardiovascular disease compared to everyone else,” said Dr. Joseph Ladapo, an associate professor of medicine at the David Geffen School of Medicine in a statement. “And they’re simultaneously less likely to be prescribed evidence-based medicine for cardiovascular disease reduction – especially statins.”
Ladapo will lead the research along with Dr. William Cunningham, a professor of medicine and public health.
The four-year award from the NIH will fund a program to educate adults with HIV about cardiovascular risk, and to encourage doctors to boost prescription rates for statins for HIV-positive patients.
Health business reporter Dana Bartholomew can be reached at firstname.lastname@example.org. Follow him on Twitter @_DanaBart.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Stem Cell Agency Awards $11 Million to SoCal Researchers to Fight Disease
- Ahmanson/UCLA Adult Congenital Heart Disease Center Earns Accreditation
- LA BioMed Gets Nearly $700,000 to Improve Heart Disease Screenings for Newborns
- UCLA Receives $5M Federal Grant to Study Early Lung Cancer Detection
- TOP DOCTORS LOS ANGELES: CARDIOLOGY
- UCLA Awarded $3.5 Million to Develop Blood Test for Liver Cancer
- City of Hope Lands Nearly $6M Grant for Stem Cell Study for Sickle Cell Disease
- UCLA Opens Heart Practice Downtown in Advance of Planned Full Health Clinic